Appointed to the Board
13 June 2012
Mr Nicholson is also Chief Executive Officer of F2G Ltd, a UK-based antifungal drug discovery and development company, Chair of Bioventix plc, a diagnostics company, non-executive director of Clinigen Group plc, a specialty pharmaceuticals and services business, and also an Operating Partner at Advent Life Sciences LLP.
Ian is Chair of the Sustainability Committee and a member of the Nomination Committee.
Key Strengths & Experience
Ian is an experienced Chief Executive and brings extensive experience in business development, licensing and mergers and acquisitions in the UK, Europe and the US.
From 2004 to 2012, Ian was Chief Executive of Chroma Therapeutics Limited, and from 2000 to 2004 Senior Vice President, Business Development at Celltech Group plc.